Immatics (IMTX) Non-Current Deferred Tax Liability (2022 - 2025)
Immatics recorded quarterly Non-Current Deferred Tax Liability of $4.4 million in Q4 2025, up 3.06% quarter-over-quarter from $4.3 million in Q3 2025, and down 28.55% year-over-year from $6.2 million in Q4 2024.
Immatics' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- In Q4 2025, Non-Current Deferred Tax Liability fell 28.55% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (down 28.55% YoY), while the FY2025 annual figure was $4.3 million, down 30.65% from the prior year.
- Non-Current Deferred Tax Liability came in at $4.4 million for Q4 2025 at Immatics, up from $4.3 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $10.0 million in Q4 2022 to a low of $3.7 million in Q3 2024.
- A 4-year average of $6.0 million and a median of $5.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 16.59% in 2025 and fell as far as 39.56% in 2025.
- Immatics' Non-Current Deferred Tax Liability stood at $10.0 million in 2022, then declined by 19.75% to $8.0 million in 2023, then decreased by 22.79% to $6.2 million in 2024, then decreased by 28.55% to $4.4 million in 2025.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $4.4 million, $4.3 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.43 Mn |
| Dec 31, 2025 | 4.43 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Mar 31, 2024 | 7.23 Mn |
| Mar 31, 2024 | 7.23 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Dec 31, 2022 | 10.01 Mn |
| Dec 31, 2022 | 10.01 Mn |